Unlike its rival Novo Nordisk, Eli Lilly anticipates substantial development in sales in 2026.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/eli-lillys-zepbound-sales-outperform-expectations/
Unlike its rival Novo Nordisk, Eli Lilly anticipates substantial development in sales in 2026.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/eli-lillys-zepbound-sales-outperform-expectations/